Indaptus Therapeutics, Inc. (INDP) stock
INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.29−0.03 (-0.90%)
Close on Nov 18, 2026Market cap $438.37MP/E –Yield –
Indaptus Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Indaptus Therapeutics's free cash flow for the twelve months ending Dec 31, 2021 was -$11.29M. For fiscal 2021 it was -$11.29M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$11.29M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | -$3.54M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.63M | – |
See a number that looks wrong?